The Unique Characteristics of MET Exon 14 Mutation in Chinese Patients with NSCLC
Si‐Yang Maggie Liu(Guangdong General Hospital), Yi‐Long Wu(Guangdong General Hospital)
Cited by 67
Related Papers
Phase II study of biomarker-guided neoadjuvant treatment strategy for IIIA-N2 non-small cell lung cancer based on epidermal growth factor receptor mutation status
|Journal of Hematology & Oncology|2015|89
miR-144-3p, a tumor suppressive microRNA targeting ETS-1 in laryngeal squamous cell carcinoma
|Oncotarget|2016|43
Molecular mechanism of the schedule-dependent synergistic interaction in EGFR-mutant non-small cell lung cancer cell lines treated with paclitaxel and gefitinib
|Journal of Hematology & Oncology|2011|33
Combinations of laminin 5 with PTEN, p-EGFR and p-Akt define a group of distinct molecular subsets indicative of poor prognosis in patients with non-small cell lung cancer
|Experimental and Therapeutic Medicine|2012|14